A phase II study of gemcitabine combined with radiation therapy in patients with localized unresectable pancreatic cancer
Ron Epelbaum(University of Bern), Abraham Kuten(Rambam Health Care Campus), E. Rosenblatt(Haifa Medical Center)
International Journal of Radiation Oncology*Biology*Physics
January 1, 2000
Cited by 5
Related Papers
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480